Phase I Study of Vasoactive Intestinal Peptide in Patients With Acute Respiratory Distress Syndrome and Sepsis

NCT00004494 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Sepsis
Respiratory Distress Syndrome
Respiratory Distress Syndrome, Adult

Interventions

DRUG: vasoactive intestinal peptide

Sponsor

Stony Brook University

Collaborators

[object Object]
[object Object]